(function(){var loadHandler=window['sl_{E3D701B7-9456-41DA-AA5D-ED55FDEB2C76}'];loadHandler&&loadHandler(3, '<div id="spr0_347ed57d"><div id="spr1_347ed57d" class="kern slide"><img id="img4_347ed57d" src="data/img1.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_347ed57d" class="kern slide"><img id="img0_347ed57d" src="data/img11.png" width="721.48" height="80.299" alt="" style="left:-1.48px;"/><div id="svg1_347ed57d" style="left:-1.48px;top:77.249px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#c76c02" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><div id="svg2_347ed57d" style="left:-1.48px;top:0.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#2e3546" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><img id="img1_347ed57d" src="data/img3.png" width="721.48" height="43.101" alt="" style="top:496.899px;"/><div id="spr3_347ed57d" style="left:657.715px;top:499.855px;"><img id="img2_347ed57d" src="data/img4.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_347ed57d" style="top:10.14px;"><div style="width:0px;"><span id="txt0_347ed57d" data-width="411.953125" style="left:155.085px;top:5.458px;">Lessons from Statin Trials</span></div></div><div id="spr5_347ed57d" style="left:4.43px;top:506.2px;"><div style="width:0px;"><span id="txt1_347ed57d" class="nokern" data-width="146.478516" style="left:7.2px;top:4.096px;">Chen et al. Can J Cardiol. 2019. 35:884-891.</span></div></div><div id="svg4_347ed57d" style="left:10.615px;top:95.207px;"><svg width="701" height="66" viewBox="0 0 701 66"><path fill="#b8bfd0" d="M0,0 h700.249 v65.433 h-700.249 Z"/></svg></div><div id="spr6_347ed57d" style="left:10.615px;top:95.207px;"><div style="width:0px;"><span id="txt2_347ed57d" data-width="270.152344" style="left:214.875px;top:4.715px;">Meta-analysis of statin trials:</span></div><div style="width:0px;"><span id="txt3_347ed57d" data-width="661.640625" style="left:19.17px;top:33.515px;">1 mmol/L reduction of LDL-C = ~22% reduction in the risk of CV events</span></div></div><div id="spr7_347ed57d" style="left:13.255px;top:180.939px;"><img id="img3_347ed57d" src="data/img12.png" width="700" height="300" alt="" style="left:0.125px;top:0.168px;"/></div></div></div>');})();